The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients-Reference-Cited by-同舟云学术

The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients

Published:2018-05-26 Issue:8 Volume:144 Page:1569-1580
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Wareham Neval E.^ORCID, ,Mocroft Amanda,Sengeløv Henrik,Da Cunha-Bang Caspar,Gustafsson Finn,Heilmann Carsten,Iversen Martin,Kirkby Nikolai S.,Rasmussen Allan,Sørensen Søren Schwartz,Lundgren Jens D.

Funder

Danmarks Grundforskningsfond

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-018-2674-9/fulltext.html

Reference24 articles.

1. Bamoulid J, Courivaud C, Coaquette A et al (2013) Subclinical Epstein–Barr virus viremia among adult renal transplant recipients: incidence and consequences. Am J Transplant 13(3):656–662

2. Dharnidharka VR (2017) Peripheral blood Epstein–Barr viral nucleic acid surveillance as a marker for posttransplant cancer risk. Am J Transplant 17(3):611–616

3. Ekenberg C, Lodding IP, Wareham NE et al (2017) Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable? Eur J Clin Microbiol Infect Dis 36:2391–2398